Abilify and Xenazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify and Xenazine. Common interactions include failure to thrive among females and dystonia among males.

The phase IV clinical study analyzes what interactions people who take Abilify and Xenazine have. It is created by eHealthMe based on reports of 62 people who take Abilify and Xenazine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 21, 2023

62 people who take Abilify and Xenazine together, and have interactions are studied.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 98,584 Abilify users for its effectiveness, alternative drugs and more.

What is Xenazine?

Xenazine has active ingredients of tetrabenazine. eHealthMe is studying from 7,292 Xenazine users for its effectiveness, alternative drugs and more.

Number of Abilify and Xenazine reports submitted per year:

Common Abilify and Xenazine drug interactions by gender *:

female:

Failure to thrive
Hypoaesthesia
Protein total decreased
Psychotic disorder
Confusional state
Headache
Hunger
Nervousness
Thirst
Agitation

male:

Dystonia
Anger
Fear
Feeling guilty
Seizure
Tourette's disorder
Verbal abuse
Aggression
Gait disturbance
Hospitalisation

Common Abilify and Xenazine drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

Abnormal behaviour
Anger
Drug administration error
Dystonia
Eye disorder
Eye movement disorder
Eyelid disorder
Fatigue
Fear
Feeling guilty

20-29:

Lip dry
Mental impairment
Personality disorder
Stress
Suicidal ideation
Crying
Akathisia
Delirium
Psychotic disorder
Blood cholesterol increased

30-39:

Insomnia

40-49:

Blood albumin decreased
Protein total decreased
Alanine aminotransferase increased
Aspartate aminotransferase increased
Blood alkaline phosphatase increased
Cytomegalovirus test positive
Decreased appetite
Dysphagia
Gamma-glutamyltransferase increased
Hepatitis cholestatic

50-59:

Nausea
Somnolence
Anxiety
Abdominal discomfort
Cerebral cyst
Cerebral haemorrhage
Cyst rupture
Dyskinesia
Feeding disorder
Myalgia

60+:

Electrocardiogram qt prolonged
Suicidal ideation
Tremor
Confusional state
Nervousness
Deafness neurosensory
Decreased appetite
Dysstasia
Dysuria
Impatience

Common conditions people have *:

Gilles De La Tourette Syndrome (a condition that causes people to make repeated, quick movements or sounds that they cannot control): 8 people, 12.90%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Xenazine?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Abilify (98,584 reports)
Xenazine (7,292 reports)